Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion
Osteoporosis is linked to higher reoperation and medical complications following lumbar fusion. Although osteoporosis medications did not significantly alter reoperation risk, their potential role in perioperative optimization requires further investigation.
Authors
- Elie Massaad (ORCID: https://orcid.org/0000-0003-4883-914X)
- Ryan Wang (ORCID: https://orcid.org/0000-0002-9681-4695)
- Joshua L. Golubovsky (ORCID: https://orcid.org/0009-0001-7045-3393)
- Tatiana Abou‐Mrad (ORCID: https://orcid.org/0009-0007-0340-5846)
- John H. Shin (ORCID: https://orcid.org/0000-0001-7490-8108)
- Syed Khalid (ORCID: https://orcid.org/0000-0003-4710-1688)
- Yohannes Ghenbot (ORCID: https://orcid.org/0000-0003-4382-9372)
- John D. Arena (ORCID: https://orcid.org/0000-0002-4322-4472)
- Ali K. Ozturk (ORCID: https://orcid.org/0000-0001-6474-9422)
Institutions
- Rosalind Franklin University of Medicine and Science (US)
- University of Illinois Chicago (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- World Neurosurgery
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.wneu.2025.124553
- Primary Topic
- Spine and Intervertebral Disc Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00